BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Emerging Risk of Peptides in Supplements LegitScript BPC 157: Miracle Healing Peptide or Hidden Danger? FDA Moves to Reevaluate Several Peptides American Med Spa Association